Science Videos

from AP, Reuters, AFP, and other news services

Ebola: Who gets access to experimental drug

Date:

August 11, 2014

Source:

AP / Powered by NewsLook.com

Summary:

The use of an experimental drug to treat two Americans and a Spaniard diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies. AP medical writer Lauran Neergaard takes a closer look. (Aug. 11)
Video provided by AP

Share This

Related Videos

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) &#151; New research shows Gilead Science&#039;s drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead&#039;s Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi&#039;s %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet&#039;s Keris Lahiff reports from New York.
Video provided by TheStreet

Federal Government Needs More Marijuana for Research Studies

TheStreet (May 9, 2014) &#151; The National Institute for Drug Abuse, or NIDA, has asked the Drug Enforcement Agency for more marijuana. NIDA has requested an increase from 21,000 grams to 650,000 grams, or roughly 1,433 pounds of pot. As of January, NIDA has funded 28 active grants related to therapeutic uses of marijuana in six different disease categories covering AIDS, pain, schizophrenia, seizures and hard drug withdrawal. But NIDA frequently contradicts on the subject of marijuana: a NIDA-funded study at Yale looking at cannabis as a treatment for schizophrenia warned that marijuana could worsen the condition. NIDA gets its pot from The University of Mississippi, the only legal marijuana farm that grows pot for the government. The request is now open to the public for comment.
Video provided by TheStreet

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) &#151; The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24)
Video provided by AP

Ebola Outbreak Spreading Unchecked

AP (Aug. 6, 2014) &#151; The Ebola outbreak has claimed more than 930 lives as world health leaders scramble to contain it and researchers focus on an experimental, unproven drug. (Aug. 6)
Video provided by AP

Related Stories

Aug. 21, 2014 — Critical ethical principles need to be adhered to if experimental drugs are to be deployed in the Ebola outbreak, bioethicists say, stating that the patients selected to receive such drugs must not ... full story

Jan. 14, 2013 — Researchers have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and ... full story

Sep. 8, 2014 — One shot of an experimental vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector, called chimp adenovirus type 3 or ChAd3, protected all four macaque ... full story

Aug. 20, 2014 — Conducting clinical studies of agents to treat Ebola and allowing compassionate use of those agents are not necessarily mutually exclusive, writes an expert. The article states that studies of, and ... full story

Mar. 5, 2015 — A physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone did not develop Ebola virus infection, and there was ... full story

Aug. 5, 2014 — Researchers are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus. Ebola virus causes ... full story

Nov. 20, 2008 — Scientists report the discovery of a new species of Ebola virus, provisionally named Bundibugyo ebolavirus. The virus, which was responsible for a hemorrhagic fever outbreak in western Uganda in ... full story

Oct. 2, 2014 — The UC Santa Cruz Genomics Institute has just released a new Ebola genome browser to assist global efforts to develop a vaccine and antiserum to help stop the spread of the Ebola ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.